Global Medicinal Tubular Glass Bottles 麻豆原创 Research Report 2025

Publication ID:

PB504251251

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Packaging [2]

Industry & Manufacturing [3]

Description:

The global market for Medicinal Tubular Glass Bottles was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medicinal Tubular Glass Bottles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicinal Tubular Glass Bottles.
The Medicinal Tubular Glass Bottles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicinal Tubular Glass Bottles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicinal Tubular Glass Bottles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
SCHOTT
Adelphi Group
Borosil
Crestani srl
DWK Life Sciences
Gerresheimer AG
NIPRO Corporation
Nuova Ompi SRL
Pacific Vials Manufacturing Inc.
Piramida d.o.o.
SGD Pharma
Segment by Type
Borosilicate Glass
Soda-lime-silica Glass
Segment by Application
Hospital
Laboratory
Pharmaceutical Company
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicinal Tubular Glass Bottles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medicinal Tubular Glass Bottles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Medicinal Tubular Glass Bottles 麻豆原创 Overview
1.1 Product Definition
1.2 Medicinal Tubular Glass Bottles by Type
1.2.1 Global Medicinal Tubular Glass Bottles 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Borosilicate Glass
1.2.3 Soda-lime-silica Glass
1.3 Medicinal Tubular Glass Bottles by Application
1.3.1 Global Medicinal Tubular Glass Bottles 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Pharmaceutical Company
1.3.5 Others
1.4 Global Medicinal Tubular Glass Bottles 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Medicinal Tubular Glass Bottles Revenue 2020-2031
1.4.2 Global Medicinal Tubular Glass Bottles Sales 2020-2031
1.4.3 Global Medicinal Tubular Glass Bottles 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medicinal Tubular Glass Bottles 麻豆原创 Competition by Manufacturers
2.1 Global Medicinal Tubular Glass Bottles Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Medicinal Tubular Glass Bottles Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Medicinal Tubular Glass Bottles Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medicinal Tubular Glass Bottles, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medicinal Tubular Glass Bottles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicinal Tubular Glass Bottles, Product Type & Application
2.7 Global Key Manufacturers of Medicinal Tubular Glass Bottles, Date of Enter into This Industry
2.8 Global Medicinal Tubular Glass Bottles 麻豆原创 Competitive Situation and Trends
2.8.1 Global Medicinal Tubular Glass Bottles 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Medicinal Tubular Glass Bottles Players 麻豆原创 Share by Revenue
2.8.3 Global Medicinal Tubular Glass Bottles 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medicinal Tubular Glass Bottles 麻豆原创 Scenario by Region
3.1 Global Medicinal Tubular Glass Bottles 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medicinal Tubular Glass Bottles Sales by Region: 2020-2031
3.2.1 Global Medicinal Tubular Glass Bottles Sales by Region: 2020-2025
3.2.2 Global Medicinal Tubular Glass Bottles Sales by Region: 2026-2031
3.3 Global Medicinal Tubular Glass Bottles Revenue by Region: 2020-2031
3.3.1 Global Medicinal Tubular Glass Bottles Revenue by Region: 2020-2025
3.3.2 Global Medicinal Tubular Glass Bottles Revenue by Region: 2026-2031
3.4 North America Medicinal Tubular Glass Bottles 麻豆原创 Facts & Figures by Country
3.4.1 North America Medicinal Tubular Glass Bottles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medicinal Tubular Glass Bottles Sales by Country (2020-2031)
3.4.3 North America Medicinal Tubular Glass Bottles Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medicinal Tubular Glass Bottles 麻豆原创 Facts & Figures by Country
3.5.1 Europe Medicinal Tubular Glass Bottles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medicinal Tubular Glass Bottles Sales by Country (2020-2031)
3.5.3 Europe Medicinal Tubular Glass Bottles Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicinal Tubular Glass Bottles 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Medicinal Tubular Glass Bottles 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medicinal Tubular Glass Bottles Sales by Region (2020-2031)
3.6.3 Asia Pacific Medicinal Tubular Glass Bottles Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medicinal Tubular Glass Bottles 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Medicinal Tubular Glass Bottles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medicinal Tubular Glass Bottles Sales by Country (2020-2031)
3.7.3 Latin America Medicinal Tubular Glass Bottles Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicinal Tubular Glass Bottles 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Medicinal Tubular Glass Bottles 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medicinal Tubular Glass Bottles Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medicinal Tubular Glass Bottles Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicinal Tubular Glass Bottles Sales by Type (2020-2031)
4.1.1 Global Medicinal Tubular Glass Bottles Sales by Type (2020-2025)
4.1.2 Global Medicinal Tubular Glass Bottles Sales by Type (2026-2031)
4.1.3 Global Medicinal Tubular Glass Bottles Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Medicinal Tubular Glass Bottles Revenue by Type (2020-2031)
4.2.1 Global Medicinal Tubular Glass Bottles Revenue by Type (2020-2025)
4.2.2 Global Medicinal Tubular Glass Bottles Revenue by Type (2026-2031)
4.2.3 Global Medicinal Tubular Glass Bottles Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Medicinal Tubular Glass Bottles Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medicinal Tubular Glass Bottles Sales by Application (2020-2031)
5.1.1 Global Medicinal Tubular Glass Bottles Sales by Application (2020-2025)
5.1.2 Global Medicinal Tubular Glass Bottles Sales by Application (2026-2031)
5.1.3 Global Medicinal Tubular Glass Bottles Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Medicinal Tubular Glass Bottles Revenue by Application (2020-2031)
5.2.1 Global Medicinal Tubular Glass Bottles Revenue by Application (2020-2025)
5.2.2 Global Medicinal Tubular Glass Bottles Revenue by Application (2026-2031)
5.2.3 Global Medicinal Tubular Glass Bottles Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Medicinal Tubular Glass Bottles Price by Application (2020-2031)
6 Key Companies Profiled
6.1 SCHOTT
6.1.1 SCHOTT Company Information
6.1.2 SCHOTT Description and Business Overview
6.1.3 SCHOTT Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SCHOTT Medicinal Tubular Glass Bottles Product Portfolio
6.1.5 SCHOTT Recent Developments/Updates
6.2 Adelphi Group
6.2.1 Adelphi Group Company Information
6.2.2 Adelphi Group Description and Business Overview
6.2.3 Adelphi Group Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Adelphi Group Medicinal Tubular Glass Bottles Product Portfolio
6.2.5 Adelphi Group Recent Developments/Updates
6.3 Borosil
6.3.1 Borosil Company Information
6.3.2 Borosil Description and Business Overview
6.3.3 Borosil Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Borosil Medicinal Tubular Glass Bottles Product Portfolio
6.3.5 Borosil Recent Developments/Updates
6.4 Crestani srl
6.4.1 Crestani srl Company Information
6.4.2 Crestani srl Description and Business Overview
6.4.3 Crestani srl Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Crestani srl Medicinal Tubular Glass Bottles Product Portfolio
6.4.5 Crestani srl Recent Developments/Updates
6.5 DWK Life Sciences
6.5.1 DWK Life Sciences Company Information
6.5.2 DWK Life Sciences Description and Business Overview
6.5.3 DWK Life Sciences Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DWK Life Sciences Medicinal Tubular Glass Bottles Product Portfolio
6.5.5 DWK Life Sciences Recent Developments/Updates
6.6 Gerresheimer AG
6.6.1 Gerresheimer AG Company Information
6.6.2 Gerresheimer AG Description and Business Overview
6.6.3 Gerresheimer AG Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gerresheimer AG Medicinal Tubular Glass Bottles Product Portfolio
6.6.5 Gerresheimer AG Recent Developments/Updates
6.7 NIPRO Corporation
6.7.1 NIPRO Corporation Company Information
6.7.2 NIPRO Corporation Description and Business Overview
6.7.3 NIPRO Corporation Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NIPRO Corporation Medicinal Tubular Glass Bottles Product Portfolio
6.7.5 NIPRO Corporation Recent Developments/Updates
6.8 Nuova Ompi SRL
6.8.1 Nuova Ompi SRL Company Information
6.8.2 Nuova Ompi SRL Description and Business Overview
6.8.3 Nuova Ompi SRL Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nuova Ompi SRL Medicinal Tubular Glass Bottles Product Portfolio
6.8.5 Nuova Ompi SRL Recent Developments/Updates
6.9 Pacific Vials Manufacturing Inc.
6.9.1 Pacific Vials Manufacturing Inc. Company Information
6.9.2 Pacific Vials Manufacturing Inc. Description and Business Overview
6.9.3 Pacific Vials Manufacturing Inc. Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pacific Vials Manufacturing Inc. Medicinal Tubular Glass Bottles Product Portfolio
6.9.5 Pacific Vials Manufacturing Inc. Recent Developments/Updates
6.10 Piramida d.o.o.
6.10.1 Piramida d.o.o. Company Information
6.10.2 Piramida d.o.o. Description and Business Overview
6.10.3 Piramida d.o.o. Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Piramida d.o.o. Medicinal Tubular Glass Bottles Product Portfolio
6.10.5 Piramida d.o.o. Recent Developments/Updates
6.11 SGD Pharma
6.11.1 SGD Pharma Company Information
6.11.2 SGD Pharma Description and Business Overview
6.11.3 SGD Pharma Medicinal Tubular Glass Bottles Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SGD Pharma Medicinal Tubular Glass Bottles Product Portfolio
6.11.5 SGD Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicinal Tubular Glass Bottles Industry Chain Analysis
7.2 Medicinal Tubular Glass Bottles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicinal Tubular Glass Bottles Production Mode & Process Analysis
7.4 Medicinal Tubular Glass Bottles Sales and 麻豆原创ing
7.4.1 Medicinal Tubular Glass Bottles Sales Channels
7.4.2 Medicinal Tubular Glass Bottles Distributors
7.5 Medicinal Tubular Glass Bottles Customer Analysis
8 Medicinal Tubular Glass Bottles 麻豆原创 Dynamics
8.1 Medicinal Tubular Glass Bottles Industry Trends
8.2 Medicinal Tubular Glass Bottles 麻豆原创 Drivers
8.3 Medicinal Tubular Glass Bottles 麻豆原创 Challenges
8.4 Medicinal Tubular Glass Bottles 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

SCHOTT
Adelphi Group
Borosil
Crestani srl
DWK Life Sciences
Gerresheimer AG
NIPRO Corporation
Nuova Ompi SRL
Pacific Vials Manufacturing Inc.
Piramida d.o.o.
SGD Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.